NO20022246L - Behandling av subnormal benmineraltetthet - Google Patents
Behandling av subnormal benmineraltetthetInfo
- Publication number
- NO20022246L NO20022246L NO20022246A NO20022246A NO20022246L NO 20022246 L NO20022246 L NO 20022246L NO 20022246 A NO20022246 A NO 20022246A NO 20022246 A NO20022246 A NO 20022246A NO 20022246 L NO20022246 L NO 20022246L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- bone mineral
- mineral density
- individual
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/225—Calcitonin gene related peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16508999P | 1999-11-12 | 1999-11-12 | |
US09/710,729 US6605591B1 (en) | 1999-11-12 | 2000-11-10 | Treatment of subnormal bone mineral density |
PCT/US2000/030131 WO2001035975A2 (en) | 1999-11-12 | 2000-11-13 | Treatment of subnormal bone mineral density |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20022246D0 NO20022246D0 (no) | 2002-05-10 |
NO20022246L true NO20022246L (no) | 2002-07-03 |
Family
ID=26861107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20022246A NO20022246L (no) | 1999-11-12 | 2002-05-10 | Behandling av subnormal benmineraltetthet |
Country Status (16)
Country | Link |
---|---|
US (3) | US6605591B1 (pt) |
EP (1) | EP1231983B1 (pt) |
JP (1) | JP2003514026A (pt) |
KR (1) | KR20020063183A (pt) |
CN (1) | CN1411386A (pt) |
AT (1) | ATE326265T1 (pt) |
AU (1) | AU784160B2 (pt) |
BR (1) | BR0015534A (pt) |
CA (1) | CA2390431A1 (pt) |
DE (1) | DE60028074D1 (pt) |
IL (1) | IL149532A0 (pt) |
MX (1) | MXPA02004776A (pt) |
NO (1) | NO20022246L (pt) |
NZ (1) | NZ518791A (pt) |
RU (1) | RU2002115815A (pt) |
WO (1) | WO2001035975A2 (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6605591B1 (en) * | 1999-11-12 | 2003-08-12 | Genelabs Technologies, Inc. | Treatment of subnormal bone mineral density |
US7660453B2 (en) | 2000-10-11 | 2010-02-09 | Imaging Therapeutics, Inc. | Methods and devices for analysis of x-ray images |
US8639009B2 (en) | 2000-10-11 | 2014-01-28 | Imatx, Inc. | Methods and devices for evaluating and treating a bone condition based on x-ray image analysis |
DE60233485D1 (de) | 2001-05-25 | 2009-10-08 | Imaging Therapeutics Inc | Verfahren zur diagnose, behandlung und prävention von knochenverlust |
US7840247B2 (en) * | 2002-09-16 | 2010-11-23 | Imatx, Inc. | Methods of predicting musculoskeletal disease |
US8965075B2 (en) * | 2002-09-16 | 2015-02-24 | Imatx, Inc. | System and method for predicting future fractures |
EP1605824A2 (en) | 2003-03-25 | 2005-12-21 | Imaging Therapeutics, Inc. | Methods for the compensation of imaging technique in the processing of radiographic images |
US20050014734A1 (en) * | 2003-07-18 | 2005-01-20 | Genovate Biotechnology Co., Ltd. | Modulation of interleukin-10 by DHEA |
US20080058613A1 (en) * | 2003-09-19 | 2008-03-06 | Imaging Therapeutics, Inc. | Method and System for Providing Fracture/No Fracture Classification |
CA2580726A1 (en) | 2004-09-16 | 2006-03-30 | Imaging Therapeutics, Inc. | System and method of predicting future fractures |
PT2460515T (pt) * | 2007-08-09 | 2017-04-27 | Novartis Ag | Composições orais de calcitonina e suas aplicações |
AU2009253839B2 (en) * | 2008-06-03 | 2011-07-28 | John Ray Biffin | A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin K |
US8939917B2 (en) | 2009-02-13 | 2015-01-27 | Imatx, Inc. | Methods and devices for quantitative analysis of bone and cartilage |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5175146A (en) | 1989-12-05 | 1992-12-29 | Vical, Inc. | Synthetic calcitonin peptides |
WO1994008589A1 (en) | 1992-10-09 | 1994-04-28 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of systemic lupus erythematosus with dehydroepiandrosterone |
US5776923A (en) | 1993-01-19 | 1998-07-07 | Endorecherche, Inc. | Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
US5912014A (en) | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
AU743121B2 (en) | 1996-11-25 | 2002-01-17 | Merck & Co., Inc. | Androgenic and bisphosphonic agents coadministered to treat diseases |
KR20000071039A (ko) * | 1997-02-13 | 2000-11-25 | 비숍 찰스 더블유. | 비타민 d 화합물의 표적화된 치료학적 전달 |
CN100544726C (zh) | 1999-03-18 | 2009-09-30 | 基因实验室技术公司 | Dhea制剂及方法 |
US7045513B1 (en) | 1999-03-18 | 2006-05-16 | Genelabs Technologies, Inc. | DHEA composition and method |
US6605591B1 (en) * | 1999-11-12 | 2003-08-12 | Genelabs Technologies, Inc. | Treatment of subnormal bone mineral density |
-
2000
- 2000-11-10 US US09/710,729 patent/US6605591B1/en not_active Expired - Fee Related
- 2000-11-13 MX MXPA02004776A patent/MXPA02004776A/es active IP Right Grant
- 2000-11-13 RU RU2002115815/14A patent/RU2002115815A/ru not_active Application Discontinuation
- 2000-11-13 BR BR0015534-9A patent/BR0015534A/pt not_active IP Right Cessation
- 2000-11-13 AT AT00978330T patent/ATE326265T1/de not_active IP Right Cessation
- 2000-11-13 KR KR1020027006101A patent/KR20020063183A/ko not_active Application Discontinuation
- 2000-11-13 WO PCT/US2000/030131 patent/WO2001035975A2/en active IP Right Grant
- 2000-11-13 EP EP00978330A patent/EP1231983B1/en not_active Expired - Lifetime
- 2000-11-13 JP JP2001537966A patent/JP2003514026A/ja not_active Withdrawn
- 2000-11-13 DE DE60028074T patent/DE60028074D1/de not_active Expired - Lifetime
- 2000-11-13 CN CN00817384A patent/CN1411386A/zh active Pending
- 2000-11-13 NZ NZ518791A patent/NZ518791A/en unknown
- 2000-11-13 CA CA002390431A patent/CA2390431A1/en not_active Abandoned
- 2000-11-13 IL IL14953200A patent/IL149532A0/xx unknown
- 2000-11-13 AU AU15802/01A patent/AU784160B2/en not_active Ceased
-
2002
- 2002-05-10 NO NO20022246A patent/NO20022246L/no not_active Application Discontinuation
-
2003
- 2003-02-13 US US10/367,218 patent/US6854468B2/en not_active Expired - Fee Related
-
2004
- 2004-12-28 US US11/024,557 patent/US7612034B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2001035975A2 (en) | 2001-05-25 |
ATE326265T1 (de) | 2006-06-15 |
RU2002115815A (ru) | 2004-02-27 |
KR20020063183A (ko) | 2002-08-01 |
US20050113301A1 (en) | 2005-05-26 |
WO2001035975A3 (en) | 2001-12-27 |
DE60028074D1 (de) | 2006-06-22 |
US7612034B2 (en) | 2009-11-03 |
EP1231983B1 (en) | 2006-05-17 |
US20030158159A1 (en) | 2003-08-21 |
CA2390431A1 (en) | 2001-05-25 |
AU1580201A (en) | 2001-05-30 |
EP1231983A2 (en) | 2002-08-21 |
CN1411386A (zh) | 2003-04-16 |
NZ518791A (en) | 2004-03-26 |
JP2003514026A (ja) | 2003-04-15 |
BR0015534A (pt) | 2002-07-02 |
AU784160B2 (en) | 2006-02-16 |
IL149532A0 (en) | 2002-11-10 |
MXPA02004776A (es) | 2003-01-28 |
US6854468B2 (en) | 2005-02-15 |
US6605591B1 (en) | 2003-08-12 |
NO20022246D0 (no) | 2002-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20022246D0 (no) | Behandling av subnormal benmineraltetthet | |
DK0880350T3 (da) | Behandling af dissemineret sklerose | |
PL336788A1 (en) | Probucol monoesters in treating circulatory system and inflammatory diseases | |
GB9927379D0 (en) | Emulsion for well and formation treatment | |
BG105534A (en) | 5ht1 means and method for the treatment of migraine | |
HUP0102951A3 (en) | Apparatus for treatment of meniere's disease and similar conditions | |
WO2001010375A3 (en) | Inhibition of action potentials | |
BR9708362A (pt) | Utilização de uma quantidade eficaz de um extrato e processo de tratamento cosmético | |
ZA98721B (en) | Use of dehydroepiandrosterone to treat primary adrenal insufficiency and addison's disease. | |
DE69833971D1 (de) | Verfahren zur behandlung von alzheimerschen krankheit | |
HK1040053A1 (en) | Use of fused pyrrolocarbazoles for preventing/treating damage to sensory hair cells and cochlear neurons | |
AUPP674898A0 (en) | A method of treatment | |
AU6083301A (en) | Treating eczema and/or psoriasis | |
GB2331301C (en) | Galanin | |
AU4370900A (en) | Treatment of systemic lupus erythematosis | |
AU4946699A (en) | Method of treating meniere's disease and corresponding apparatus | |
HK1019702A1 (en) | Use of (+)-alpha-(2,3-dimethoxyphenyl)ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders | |
ZA981781B (en) | The use of levobupivacaine in treating migraine | |
HUP9900007A2 (hu) | Készítmény baromfialom kezelésére | |
BA98363A (bs) | Postupak i uredaj za tretiranje koze i tome slicno | |
EP1009433A4 (en) | THERAPEUTIC COMPOSITION AND TREATMENT METHOD | |
EP0745597A3 (en) | Novel melatonergic indanyl piperazines or homopiperazines | |
ATE282398T1 (de) | Verfahren zum dauerwellen von menschlichen haaren | |
GB9709815D0 (en) | Therapeutic method | |
IT1285552B1 (it) | Dispositivo e metodo per il trattamento di parti del corpo umano |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |